🔗 Share this article

An underground market for unapproved slimming drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Experimental Drug Gaining Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are encouraged to message these accounts privately for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of members share comparison images, administration instructions and assertions of rapid British shipping. Vendors promote the substance there before directing buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, physicians and pharmacists have warned that the sale of what remains an unlicensed medication in the UK is worrisome and could result in individuals administering substances of unknown origin.

Several professionals stated the demand for the experimental drug could be connected to the rising price of licensed slimming products such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach pharmaceutical, advertising, and customer regulations, risking fines, legal action or prison.

Service Response and Content Elimination

Based on the social media company, the service has removed violative content and banned related hashtags and search suggestions. The company said it was dedicated to maintaining the service secure and investing in enhancing compliance measures.

Online Marketplace Operations

Research also discovered groups with up to 9,000 participants selling the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, filled with photos of weight loss, positive reviews and detailed instructions for preparing or injecting at residence.

Within minutes of entering one group, a vendor shared WhatsApp details, where the majority of purchases occur. The vendor provided an guidebook and promised delivery within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about weight, health issues or previous experience.

Item Information and Pricing

Within these communities, messages show dark colored packages with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with purified liquid, or ready-to-use pens usually priced at £160 for 20mg. When questioned how long a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for Telegram said it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting materials they can’t verify. Even if the research behind retatrutide is sound, these online products may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With costs rising, patients are using online platforms. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has already encountered patients injured by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to potentially significant health risks”.